Cargando…

Acquired Resistance to Tuberculosis: A Factor in Clinical Type and Prognosis

Detalles Bibliográficos
Autor principal:	Cummins, S. Lyle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	J.W. Arrowsmith 1923
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5057638/ https://www.ncbi.nlm.nih.gov/pubmed/28897420

Ejemplares similares

The Tuberculosis of Tropical Countries: Primitive Tuberculosis and the Partially Modified Disease
por: Cummins, S. Lyle
Publicado: (1939)

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
por: Andries, Koen, et al.
Publicado: (2014)

Acquired Drug Resistance in Mycobacterium tuberculosis and Poor Outcomes among Patients with Multidrug-Resistant Tuberculosis
por: Kempker, Russell R., et al.
Publicado: (2015)

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants
por: Odone, Anna, et al.
Publicado: (2016)

Resistance to Tuberculosis: Experimental Studies in Native and Acquired Defensive Mechanisms
por: Sulavik, Stephen B.
Publicado: (1966)

Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review
por: Mallick, Jahan Saeed, et al.
Publicado: (2022)

Characteristics of Previous Tuberculosis Treatment History in Patients with Treatment Failure and the Impact on Acquired Drug-Resistant Tuberculosis
por: Soedarsono, Soedarsono, et al.
Publicado: (2023)

Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal Cancer
por: Zhuo, Na, et al.
Publicado: (2022)

Clinical characteristics and prognosis of acquired perforating dermatosis: A case report
por: Wang, Mei-Fang, et al.
Publicado: (2020)

Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide
por: Petrella, Stéphanie, et al.
Publicado: (2011)

Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance
por: Yuen, Courtney M., et al.
Publicado: (2013)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Factors in Resistance to Tuberculosis
por: Gerstl, B., et al.
Publicado: (1941)

Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
por: Timm, Juliano, et al.
Publicado: (2023)

Clinical factors associated with composition of lung microbiota and important taxa predicting clinical prognosis in patients with severe community-acquired pneumonia
por: Du, Sisi, et al.
Publicado: (2021)

Primary and acquired multidrug-resistant tuberculosis: Predictive factors for unfavorable treatment outcomes in Rio de Janeiro, 2000–2016
por: Bhering, Marcela, et al.
Publicado: (2020)

Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis
por: Ngabonziza, Jean Claude Semuto, et al.
Publicado: (2020)

Prevalence of resistance and toxin genes in community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus clinical isolates
por: El-Baghdady, Khaled Z., et al.
Publicado: (2020)

Prognosis in Pulmonary Tuberculosis
por: Fraser, R.
Publicado: (1947)

The Prognosis of Pulmonary Tuberculosis
por: Lucas, J. J. S.
Publicado: (1906)

Factors That Negatively Affect the Prognosis of Pediatric Community-Acquired Pneumonia in District Hospital in Tanzania
por: Caggiano, Serena, et al.
Publicado: (2017)

Antimicrobial Resistance and Clinical Outcomes in Nursing Home-Acquired Pneumonia, Compared to Community-Acquired Pneumonia
por: Kang, Yun-Seong, et al.
Publicado: (2017)

Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia
por: Idigo, Adeniyi J., et al.
Publicado: (2022)

Waiting to inhale: factors associated with healthcare workers’ fears of occupationally-acquired tuberculosis (TB)
por: Engelbrecht, Michelle, et al.
Publicado: (2019)

EXPERIMENTAL EPIDEMIOLOGY OF TUBERCULOSIS : THE ROUTE OF INFECTION IN NATURALLY ACQUIRED TUBERCULOSIS OF THE GUINEA PIG
por: Lurie, Max B.
Publicado: (1930)

No Evidence for Acquired Mutations Associated with Cytochrome bc(1) Inhibitor Resistance in 13,559 Clinical Mycobacterium tuberculosis Complex Isolates
por: Rybniker, Jan, et al.
Publicado: (2018)

Tuberculosis Acquired Outside of Households, Rural Vietnam
por: Buu, Tran N., et al.
Publicado: (2010)

Acquired and Transmitted Multidrug-Resistant Tuberculosis among the Incarcerated Population and Its Determinants in the State of Paraná—Brazil
por: dos Santos, Márcio Souza, et al.
Publicado: (2022)

Prognosis in Pulmonary Tuberculosis
por: Squire, J. Edward
Publicado: (1909)

Prognosis in Pulmonary Tuberculosis
por: Lapham, Mary
Publicado: (1906)

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence
por: Rockwood, Neesha, et al.
Publicado: (2017)

Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
por: Cecchi, Fabiola, et al.
Publicado: (2023)

Clinical Implications of Acquired BRAF Inhibitors Resistance in Melanoma
por: Savoia, Paola, et al.
Publicado: (2020)

Comparison of treatment outcome definitions in drug-resistant tuberculosis patients with high incidence of acquired second-line drug resistance
por: Anderson, K, et al.
Publicado: (2022)

High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence
por: Anderson, Kim, et al.
Publicado: (2022)

Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance, and clinical outcomes
por: Hyun, Hakjun, et al.
Publicado: (2022)

Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions
por: Shen, Gwan-Han, et al.
Publicado: (2012)

Potential contribution of HIV during first-line tuberculosis treatment to subsequent rifampicin-monoresistant tuberculosis and acquired tuberculosis drug resistance in South Africa: a retrospective molecular epidemiology study
por: Cox, Helen, et al.
Publicado: (2021)

Bacteremic Community-Acquired Pneumonia in Ethiopian Children: Etiology, Antibiotic Resistance, Risk Factors, and Clinical Outcome
por: Negash, Abel Abera, et al.
Publicado: (2019)

Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali()
por: Baya, Bocar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pk20muehhfi4ol6p8nqh0oh0s8